Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Tuberculosis

Free Subscription Articles published in Eur Respir J Retrieve available abstracts of 51 articles: HTML format

Single Articles

November 2025
1. POHL J, Groschel MI, Neumann N, Tillmann A, et al
   Active case finding for tuberculosis among Ukrainian soldiers at the German Armed Forces.
   Eur Respir J. 2025 Nov 6:2500728. doi: 10.1183/13993003.00728-2025.
   PubMed    
   
   
   
2. 
   "Lung function trajectories in South African children with pulmonary tuberculosis compared to those with non-TB lower respiratory tract infection: a prospective study." D.M. Gray, L. Githinji, K. Brittain, et al. Eur Respir J 2024; 63: 2400216.
   Eur Respir J. 2025;66:2450216.
   PubMed    
   
   
   August 2025
3. SCOPAZZINI M, Zenner D
   Tuberculosis preventive treatment in people living with HIV: to improve treatment completion, we need a simpler cascade of care.
   Eur Respir J. 2025;66:2500638.
   PubMed    
   
   
   
4. LANGE C, Barry C 3rd, Sotgiu G
   Linezolid for the treatment of drug-resistant tuberculosis.
   Eur Respir J. 2025;66:2500927.
   PubMed    
   
   
   July 2025
5. KWAK N, Kim JY, Han A, Berry C, et al
   Optimal dosing and duration of linezolid for the treatment of multidrug-resistant and rifampicin-resistant tuberculosis: An individual patient data meta-analysis.
   Eur Respir J. 2025 Jul 17:2500315. doi: 10.1183/13993003.00315-2025.
   PubMed     Abstract available
   
   
   
6. ORDONEZ AA, Willy Vangu MD, Rajaratnam A, Mofokeng N, et al
   Collagen-targeted PET/CT Imaging of Tuberculosis Patients.
   Eur Respir J. 2025 Jul 10:2500195. doi: 10.1183/13993003.00195-2025.
   PubMed    
   
   
   
7. DUPUIS GN, Dolynska M, Chiang SS, Horsburgh CR Jr, et al
   Risk of rifampin resistance emergence after incomplete first-line tuberculosis treatment.
   Eur Respir J. 2025 Jul 3:2500902. doi: 10.1183/13993003.00902-2025.
   PubMed    
   
   
   
8. MIGLIORI GB, Centis R, D'Ambrosio L, Rossato Silva D, et al
   Post Tuberculosis Lung Disease: questions and answers.
   Eur Respir J. 2025 Jul 3:2500992. doi: 10.1183/13993003.00992-2025.
   PubMed    
   
   
   
9. ZENNER D, Haghparast-Bidgoli H, Chaudhry T, Abubakar I, et al
   How to diagnose TB in migrants? A systematic review of reviews and decision tree analytical modelling exercise to evaluate properties for single and combined tuberculosis screening tests.
   Eur Respir J. 2025;66:2402000.
   PubMed     Abstract available
   
   
   June 2025
10. TEO AKJ, Luu KB, Garden F, Pham CD, et al
    The relationship between a known diagnosis of tuberculosis and symptom reporting: implications for case detection strategies.
    Eur Respir J. 2025 Jun 26:2402521. doi: 10.1183/13993003.02521-2024.
    PubMed    
    
    
    
11. AKKERMAN OW, Falzon D, Migliori GB, Konstantynovska O, et al
    WHO online guide on the use of digital technologies for tuberculosis programmes.
    Eur Respir J. 2025;65:2401126.
    PubMed    
    
    
    May 2025
12. DEGTYAREVA S, Hamada Y, Baggaley RF, Hassan N, et al
    Tuberculosis Preventive Treatment care pathways in people living with HIV: a systematic review and meta-analysis.
    Eur Respir J. 2025 May 1:2302174. doi: 10.1183/13993003.02174-2023.
    PubMed     Abstract available
    
    
    February 2025
13. KRAEF C, Roen A, Podlekareva D, Bakowska E, et al
    Incident tuberculosis in people with HIV across Europe from 2012-2022: incidence rates, risk factors, and regional differences in a multicentre cohort study.
    Eur Respir J. 2025 Feb 20:2401904. doi: 10.1183/13993003.01904-2024.
    PubMed     Abstract available
    
    
    January 2025
14. CANGELOSI GA, Salfinger M
    Casting a wider net for tuberculosis cases.
    Eur Respir J. 2025;65:2402245.
    PubMed    
    
    
    
15. WANG Y, Cui J, Li Y, Wang M, et al
    Rapid quantitative PCR on tongue swabs for pulmonary tuberculosis in adults: a prospective multicentre study.
    Eur Respir J. 2025;65:2401493.
    PubMed     Abstract available
    
    
    
16. LOADER MI, Vasquez Alves S, Gilman RH, Coronel J, et al
    Up-regulated matrix metalloproteinase activity in soil-transmitted helminth-tuberculosis co-infection is associated with increased lung pathology.
    Eur Respir J. 2025;65:2401445.
    PubMed     Abstract available
    
    
    December 2024
17. KUNST H, Lange B, Hovardovska O, Bockey A, et al
    Tuberculosis in adult migrants in Europe: a TBnet consensus statement.
    Eur Respir J. 2024 Dec 13:2401612. doi: 10.1183/13993003.01612-2024.
    PubMed     Abstract available
    
    
    November 2024
18. CHHABRA S, Koh MCY, Allen DM
    The treatment of latent tuberculosis infection in migrants in primary care versus secondary care.
    Eur Respir J. 2024;64:2401569.
    PubMed    
    
    
    
19. THU WPP, Loh FK, Ong CWM
    Blood RNA signatures for 8-week sputum tuberculosis culture sterilisation: how close are we?
    Eur Respir J. 2024;64:2401669.
    PubMed    
    
    
    September 2024
20. EDEM VF, Nkereuwem E, Agbla SC, Owusu SA, et al
    Accuracy of Computer-Aided Detection for Tuberculosis (R) on paediatric chest radiographs.
    Eur Respir J. 2024 Sep 3:2400811. doi: 10.1183/13993003.00811-2024.
    PubMed    
    
    
    
21. ROSENHEIM J, Abebe M, Belay M, Tulu B, et al
    Detection of M. tuberculosis DNA in TB contacts' PBMC does not associate with blood RNA signatures for incipient tuberculosis.
    Eur Respir J. 2024 Sep 3:2400479. doi: 10.1183/13993003.00479-2024.
    PubMed    
    
    
    August 2024
22. BURMAN M, Zenner D, Copas AJ, Gosce L, et al
    The treatment of latent tuberculosis infection in migrants in primary care versus secondary care.
    Eur Respir J. 2024 Aug 22:2301733. doi: 10.1183/13993003.01733-2023.
    PubMed     Abstract available
    
    
    
23. GREENAN-BARRETT J, Gupta RK, Noursadeghi M
    The end of the road for blood RNA biomarkers as triage tests for symptomatic pulmonary tuberculosis among spontaneous sputum producers?
    Eur Respir J. 2024;64:2401365.
    PubMed    
    
    
    
24. MUWANGA VM, Mendelsohn SC, Leukes V, Stanley K, et al
    Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort study.
    Eur Respir J. 2024;64:2400153.
    PubMed     Abstract available
    
    
    
25. CALDERWOOD CJ, Sanchez Martinez A, Greenan-Barrett J, Turner CT, et al
    Resolution of tuberculosis blood RNA signatures fails to discriminate persistent sputum culture positivity after eight weeks of anti-tuberculous treatment.
    Eur Respir J. 2024 Aug 1:2400457. doi: 10.1183/13993003.00457-2024.
    PubMed     Abstract available
    
    
    July 2024
26. KOSER CU, Miotto P, Ismail N, Anthony RM, et al
    A composite reference standard is needed for bedaquiline antimicrobial susceptibility testing for Mycobacterium tuberculosis complex.
    Eur Respir J. 2024;64:2400391.
    PubMed     Abstract available
    
    
    June 2024
27. JANKOVIC MAKEK M, Lovric Makaric Z, Petrovic G, Sarajlic G, et al
    New priorities for Croatia to pursue tuberculosis pre-elimination.
    Eur Respir J. 2024;63:2400279.
    PubMed    
    
    
    May 2024
28. GRAY DM, Githinji L, Brittain K, Franckling-Smith Z, et al
    Lung function trajectories in South African children with pulmonary tuberculosis (TB) compared to those with non-TB lower respiratory tract infection: A prospective study.
    Eur Respir J. 2024 May 23:2400216. doi: 10.1183/13993003.00216-2024.
    PubMed    
    
    
    
29. MESIC A, Decuyper I, Ishaq S, Azizi T, et al
    Short oral treatment regimens for rifampicin-resistant tuberculosis are safe and effective for young children: results from a field-based non-randomized clinical trial, Kandahar Afghanistan.
    Eur Respir J. 2024 May 23:2400436. doi: 10.1183/13993003.00436-2024.
    PubMed    
    
    
    April 2024
30. TRAUTH J, Kantelhardt V, Usenko B, Knipper M, et al
    Bedaquiline, pretomanid, and linezolid in multidrug-resistant and pre-extensively drug-resistant tuberculosis in refugees from Ukraine and Somalia in Germany.
    Eur Respir J. 2024 Apr 18:2400303. doi: 10.1183/13993003.00303-2024.
    PubMed    
    
    
    
31. NOGUERA-JULIAN A, Latre C, Flores A
    Availability of paediatric dispersible fixed-dose combinations of tuberculosis drugs in Spain.
    Eur Respir J. 2024;63:2400104.
    PubMed    
    
    
    January 2024
32. ALI M, El Hafid M, Farrar DS, Kourdi H, et al
    Travel-acquired paediatric tuberculosis in the Greater Toronto Area, Canada, 2002-2018.
    Eur Respir J. 2024 Jan 11:2301533. doi: 10.1183/13993003.01533-2023.
    PubMed    
    
    
    
33. 
    "Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update." S. Ghosh, L. Breitscheidel, N. Lazarevic, et al. Eur Respir J 2021; 57: 2002483.
    Eur Respir J. 2024;63:2052483.
    PubMed    
    
    
    November 2023
34. ACHAR J, Seddon JA, Knight GM, Dodd PJ, et al
    Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.
    Eur Respir J. 2023 Nov 9:2300969. doi: 10.1183/13993003.00969-2023.
    PubMed    
    
    
    
35. PERUMAL R, Bionghi N, Nimmo C, Letsoalo M, et al
    Baseline and treatment-emergent bedaquiline resistance in drug-resistant tuberculosis: A systematic review and meta-analysis.
    Eur Respir J. 2023 Nov 9:2300639. doi: 10.1183/13993003.00639-2023.
    PubMed    
    
    
    
36. ZENNER D, Cobelens F, Abubakar I
    Reply: Tuberculosis screening in migrants to the EU/EEA and UK.
    Eur Respir J. 2023;62:2301535.
    PubMed    
    
    
    
37. KOHLER N, Vasiliu A, Mandalakas AM, Martinez L, et al
    Tuberculosis screening in migrants to the EU/EEA and UK.
    Eur Respir J. 2023;62:2301230.
    PubMed    
    
    
    
38. DIEL R, Schluger NW
    Long-term outcome of co-infection of COVID-19 and tuberculosis: the "cursed duet".
    Eur Respir J. 2023;62:2301881.
    PubMed    
    
    
    
39. CASCO N, Jorge AL, Palmero DJ, Alffenaar JW, et al
    Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.
    Eur Respir J. 2023;62:2300925.
    PubMed     Abstract available
    
    
    October 2023
40. DEN BOON S, Yedilbayev A
    Screening for tuberculosis among migrants in Europe: harmonising approaches during a humanitarian crisis?
    Eur Respir J. 2023;62:2301537.
    PubMed    
    
    
    
41. AGUIAR SOARES K, Ehrlich J, Camara M, Chaloub S, et al
    Implementation of WHO guidelines on urine lateral flow LAM testing in high TB/HIV burden African countries.
    Eur Respir J. 2023;62:2300556.
    PubMed    
    
    
    
42. ZENNER D, Brals D, Nederby-Ohd J, Menezes D, et al
    Drivers determining tuberculosis disease screening yield in four European screening programmes: a comparative analysis.
    Eur Respir J. 2023;62:2202396.
    PubMed     Abstract available
    
    
    September 2023
43. RIOU C, du Bruyn E, Kim GHJ, da Costa I, et al
    Derivation of a high-resolution CT-based, semi-automated radiographic score in tuberculosis and its relationship to bacillary load and antitubercular therapy.
    Eur Respir J. 2023 Sep 7:2300600. doi: 10.1183/13993003.00600-2023.
    PubMed    
    
    
    
44. BYRNE A, Allwood B, Schoeman I, Johnston J, et al
    "Post tuberculosis": the urgent need for inclusion of lung health outcomes in tuberculosis treatment trials.
    Eur Respir J. 2023;62:2300950.
    PubMed     Abstract available
    
    
    August 2023
45. STOCKER SL, Alffenaar JC
    Predicting early bactericidal activity using pre-clinical data for tuberculosis drugs: a platform for model-informed drug discovery and development.
    Eur Respir J. 2023;62:2301108.
    PubMed    
    
    
    
46. ERNEST JP, Goh JJN, Strydom N, Wang Q, et al
    Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs.
    Eur Respir J. 2023;62:2300165.
    PubMed     Abstract available
    
    
    June 2023
47. MIGLIORI GB, Dowdy D, Denholm JT, D'Ambrosio L, et al
    The path to tuberculosis elimination: a renewed vision.
    Eur Respir J. 2023;61:2300499.
    PubMed     Abstract available
    
    
    
48. 
    June Podcast: Path to tuberculosis elimination.
    Eur Respir J. 2023;61:23E6106.
    PubMed    
    
    
    May 2023
49. KOSER CU, Maurer FP
    Minimum inhibitory concentrations and sequencing data have to be analysed in more detail to set provisional epidemiological cut-off values for Mycobacterium tuberculosis complex.
    Eur Respir J. 2023;61:2202397.
    PubMed    
    
    
    
50. 
    Reply: Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis.
    Eur Respir J. 2023;61:2300426.
    PubMed     Abstract available
    
    
    
51. KAHLMETER G, Turnidge J
    The determination of epidemiological cut-off values requires a systematic and joint approach based on quality controlled, non-truncated minimum inhibitory concentration series.
    Eur Respir J. 2023;61:2202259.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.